Diverticulitis is not an inflammatory bowel disease. Despite the word “inflammatory” fitting both conditions, medical classification draws a firm line between diverticulitis and the two conditions that make up IBD: Crohn’s disease and ulcerative colitis. The confusion is understandable, though, because the two share some surface-level features and can even be tricky to tell apart under a microscope. The relationship between them is more nuanced than a simple “completely different diseases” dismissal would suggest.
What Separates Diverticulitis From IBD
The simplest way to understand the distinction is to look at what each condition actually is. Diverticulitis starts with a structural problem. Small pouches called diverticula form in weak spots of the colon wall, typically where blood vessels pass through the muscle layer.1PubMed Central. Diverticulosis and Diverticulitis When one or more of those pouches become inflamed or infected, that is diverticulitis. The inflammation is a consequence of a mechanical defect in the bowel wall, not the primary disease itself.
IBD, by contrast, is driven by a malfunctioning immune system. In Crohn’s disease and ulcerative colitis, the body’s immune defenses turn on the gut lining, causing chronic, relapsing inflammation.2World Journal of Gastroenterology. Circadian clock at the interface of mucosal immunity, gut microbiota and epithelial barrier in inflammatory bowel disease This involves breakdowns in the intestinal barrier, shifts in gut bacteria, and an overactive adaptive immune response, with T cells and other immune cells attacking the bowel’s own tissue.3PubMed. Defects in mucosal immunity leading to Crohn’s disease IBD is a lifelong autoimmune-related condition. Diverticulitis is typically an acute episode that resolves, though it can recur.
So while both conditions produce inflammation in the colon and can cause overlapping symptoms like abdominal pain, fever, and changes in bowel habits, their underlying causes are fundamentally different. One is a plumbing problem that gets infected; the other is an immune system problem that never fully switches off.
Why the Two Get Confused
Part of the confusion comes from symptoms. A flare of left-sided Crohn’s disease can look a lot like acute diverticulitis on a CT scan or during a clinical exam. Both can cause localized pain, bowel wall thickening, and even abscesses or fistulas. In older adults who already have diverticula (which become very common with age), distinguishing a diverticulitis episode from a Crohn’s flare can genuinely challenge clinicians.
The confusion also runs deeper than symptoms. When pathologists examine tissue removed during surgery for diverticulitis, they sometimes find changes that look strikingly similar to Crohn’s disease: granulomas, chronic inflammation in the deeper tissue layers, and architectural distortion of the glands. A study examining sigmoid colon specimens concluded that these Crohn’s-like changes in diverticulitis tissue are usually just an unusual inflammatory reaction to the diverticula themselves, not evidence of coexisting Crohn’s disease.4PubMed. Crohn’s colitis-like changes in sigmoid diverticulitis specimens is usually an idiosyncratic inflammatory response to the diverticulosis rather than Crohn’s colitis The researchers cautioned pathologists against diagnosing Crohn’s disease in the context of diverticulitis unless there is evidence of Crohn’s elsewhere in the bowel.
That warning exists because getting it wrong has real consequences. A misdiagnosis of Crohn’s in someone who actually has diverticulitis could mean unnecessary immunosuppressive drugs. Going the other direction, dismissing Crohn’s as “just diverticulitis” could delay treatment that prevents serious bowel damage.
How Diverticulitis Actually Develops
For a long time, doctors assumed diverticulitis worked much like appendicitis: a small piece of stool gets trapped in a diverticulum, blocks the opening, and bacteria multiply behind the blockage until the pouch becomes inflamed and potentially perforates. That model has been challenged. Anatomic studies have found inflammation and tiny perforations in diverticula even when no trapped stool is present.5International Journal of Surgery Research and Practice. Why Does Diverticulitis Perforate? Reduced blood flow to segments of the colon loaded with diverticula also appears to play a role, since the pouches can distort the normal blood vessel architecture within the bowel wall.
Perforation, the most feared complication, can result from a combination of inflammation, infection, and localized loss of blood supply.6PubMed Central. Diverticulitis With Microperforation Most episodes of diverticulitis are uncomplicated and resolve with conservative treatment or antibiotics. Roughly one in five people who have a first episode will have at least one recurrence, but complications like abdominal sepsis become less likely with subsequent episodes rather than more.7PubMed Central. Epidemiology, Pathophysiology, and Treatment of Diverticulitis
The Hypothesis That Diverticulitis Might Be a Form of IBD
While mainstream medicine keeps the two conditions in separate categories, the idea that diverticulitis could sit somewhere on the IBD spectrum has been formally proposed. A hypothesis published in the Journal of Clinical Gastroenterology suggested that changes in the gut bacterial environment around diverticula may trigger low-grade chronic inflammation in the mucosal lining, essentially setting the stage for acute diverticulitis in a process that mirrors early IBD.8PubMed Central. A hypothesis: is diverticulitis a type of inflammatory bowel disease? The authors pointed to early evidence that medications used for IBD, including mesalamine (an anti-inflammatory drug commonly prescribed for ulcerative colitis) and probiotics, seemed to help with diverticulitis.
This remains a hypothesis, not an accepted reclassification. But it reflects a real observation: in some patients, the tissue surrounding diverticula shows signs of ongoing, low-grade inflammation even between acute episodes. That smoldering inflammation is more consistent with how IBD behaves than with a simple mechanical blockage-and-infection model.
SCAD, the Condition That Blurs the Line
If you want to see how blurry the boundary between diverticular disease and IBD can get, look at segmental colitis associated with diverticulosis, or SCAD. This is a relatively rare condition where inflammation develops in the stretches of colon between diverticula rather than inside them. The inflamed mucosa shows swelling, easy bleeding, and erosions affecting the tissue between the pouches.9PubMed Central. Segmental Colitis Associated With Diverticulosis Under the microscope, SCAD tissue can show chronic colitis changes including crypt distortion and even granulomas, features that gastroenterologists associate with IBD.
The question of whether SCAD is its own disease or actually belongs on the IBD spectrum remains unresolved. Research has noted that not only does SCAD present like IBD clinically, but it can closely mimic the tissue-level changes of both ulcerative colitis and Crohn’s disease.10Clinical Gastroenterology and Hepatology. Clinical, Endoscopic, and Radiographic Characteristics of Segmental Colitis Associated With Diverticulosis The endoscopic and pathological similarities between SCAD and IBD are well documented.11PubMed Central. Endoscopic and clinicopathological features of segmental colitis associated with diverticulosis
SCAD matters to patients because it can be misdiagnosed as either IBD or standard diverticulitis, and the management differs for each. Most SCAD patients respond well to mesalamine or topical steroids, with mesalamine often continued as maintenance therapy. Only the most severe cases require the stronger immunosuppressive drugs used in refractory IBD.12PubMed Central. Considerations and Changes in the Evaluation, Management, and Outcomes in the Management of Diverticular Disease: The Diagnosis, Pathology, and Treatment of Diverticular Colitis If you have been diagnosed with diverticular disease and are being treated with mesalamine, it is worth understanding that your doctor may be managing an inflammatory component that overlaps with how IBD is treated, even though the formal diagnosis is different.
Genetic Evidence Points to Different Diseases
Genetics offers some of the clearest evidence that diverticular disease and IBD are distinct. A large genome-wide analysis found that the genetic risk variants for diverticular disease are enriched in genes active in muscle cells, connective tissue cells, and the nerve-like cells that coordinate bowel movement. The genetic variants linked to Crohn’s disease and ulcerative colitis, by contrast, cluster around genes active in immune cells like T cells and macrophages, as well as the epithelial cells lining the gut.13Cell Genomics. Genome-wide association analysis implicates new loci, and cell types and mechanisms for diverticular disease
This fits the broader picture. Diverticular disease is fundamentally about the structural integrity of the colon wall, with the muscle and connective tissue that hold it together. IBD is fundamentally about immune regulation at the gut lining. The genetic architecture of each condition reflects its core biology. There is some overlap in nerve and glial cell involvement, which might explain why both conditions affect bowel motility and sensation, but the primary genetic signatures point in very different directions.
The Microbiome Connection
One area where diverticular disease and IBD genuinely overlap is the gut microbiome. Altered bacterial communities in the colon have been linked to both conditions, and a systematic review of the evidence noted a possible overlap between acute diverticulitis and IBD through shared patterns of microbial disruption.14PubMed Central. Gut Microbiota Association with Diverticular Disease Pathogenesis and Progression: A Systematic Review The review suggested that because IBD is already well established as involving altered gut bacteria, similar disruption patterns could contribute to diverticular disease progression.
This is where the science gets genuinely interesting but also genuinely uncertain. It is not clear whether the microbial changes in diverticular disease are a cause or a consequence. Diverticula create pockets where stool and bacteria can stagnate, which could alter the local bacterial environment as a result of the structural problem rather than as its origin. In IBD, the immune dysfunction itself reshapes the microbial community. The end result may look similar on a bacterial census, but the chain of causation could be completely different.
When You Have Both
Because diverticula are extremely common in adults over 60 and IBD can strike at any age, some patients genuinely have both conditions at the same time. This creates a clinical headache. A Crohn’s patient who develops diverticulitis needs careful evaluation to determine which disease is causing the current symptoms, because the treatments diverge. Immunosuppressive drugs used for Crohn’s can raise infection risk, which is concerning if the real problem is an infected diverticulum that might perforate. Conversely, managing what appears to be diverticulitis with antibiotics alone will not address an underlying Crohn’s flare.
Surgeons face a related challenge. Specimens removed during diverticulitis surgery sometimes show inflammatory patterns that raise the question of Crohn’s disease. As the pathology research discussed earlier established, those patterns are usually a reaction to the diverticula rather than a sign of IBD. But “usually” is not “always,” and patients with truly ambiguous findings need follow-up colonoscopy once the acute episode resolves, ideally with biopsies from multiple bowel segments to check for inflammation elsewhere.
Diverticulitis and Colon Cancer Risk
A question that comes up alongside the IBD comparison is whether diverticulitis, like IBD, raises the risk of colon cancer. IBD is a well-recognized cancer risk factor, particularly ulcerative colitis affecting a large portion of the colon. For diverticulitis, the picture is different. A large registry-based study found that the rate of colon cancer was about 2.1% in people with diverticulitis compared to 1.5% in matched controls. The elevated risk was concentrated in the first six months after the diverticulitis diagnosis, with a hazard ratio of 1.7 during that window. After six months, people in the diverticulitis group actually had a slightly lower cancer risk than controls.15PubMed Central. Diverticulitis Is Associated with Increased Risk of Colon Cancer—A Nationwide Register-Based Cohort Study
That early spike probably reflects detection bias: when someone shows up with diverticulitis, they get imaging and often a follow-up colonoscopy, which catches cancers that were already there but had not yet caused symptoms. The finding that long-term risk is actually lower after the initial diagnostic workup supports this interpretation. This is very different from the cancer risk in IBD, where years of chronic inflammation gradually increase the odds of malignant change in the colon lining. Diverticulitis does not appear to carry the same kind of cumulative, inflammation-driven cancer risk that IBD does.
Shared Treatments, Different Reasons
One of the things that feeds the “is it really IBD?” question is the fact that some of the same medications are used for both conditions. Mesalamine, the workhorse drug for mild to moderate ulcerative colitis, is also prescribed for some diverticular disease patients, particularly those with SCAD or recurrent symptomatic diverticular disease. The hypothesis paper proposing diverticulitis as a possible IBD variant cited early reports of mesalamine’s benefit in diverticulitis as supporting evidence.8PubMed Central. A hypothesis: is diverticulitis a type of inflammatory bowel disease?
But sharing a treatment does not mean sharing a disease. Mesalamine reduces mucosal inflammation regardless of what triggered it. Aspirin treats headaches and heart attacks, but those are not the same condition. The fact that an anti-inflammatory drug helps in both IBD and some forms of diverticular disease tells us that inflammation is a component of both, which no one disputes. It does not tell us that the diseases are the same or that they belong in the same classification.
Where the treatment paths diverge sharply is in the heavy-duty end of the drug arsenal. Biologic therapies targeting specific immune molecules, like TNF inhibitors or interleukin blockers, are mainstays of moderate-to-severe IBD management. These drugs are not part of standard diverticulitis care. If anything, the immunosuppression they cause would be counterproductive in a disease where localized bacterial infection is the proximate problem. The therapeutic overlap is real but narrow, confined mainly to mild anti-inflammatory agents rather than the immune-modulating drugs that define modern IBD treatment.
What This Means if You Have Been Diagnosed
If you have diverticulitis and are wondering whether it could actually be IBD, the practical answer for most people is no, your doctor has it right. The two conditions look different on CT scans, colonoscopies, and blood work in the vast majority of cases. Diverticulitis episodes are typically acute and self-limited, while IBD tends to follow a chronic relapsing pattern with periods of remission and flare.
There are situations where pushing for a closer look makes sense. If your “diverticulitis” keeps recurring despite treatment, if inflammation is found in parts of the colon where you do not have diverticula, or if biopsies show granulomas or other features more consistent with Crohn’s disease, your gastroenterologist should consider the possibility that something else is going on. SCAD is another possibility worth discussing if your inflammation is concentrated between diverticula rather than inside them, since it responds to different treatment than standard diverticulitis and may carry a different long-term outlook.
The science continues to evolve. The neat boundary between “structural disease with secondary inflammation” and “primary immune-driven inflammation” may turn out to be less absolute than current classification suggests. For now, though, diverticulitis and IBD remain separate diagnoses with different treatment strategies, different long-term monitoring needs, and different genetic underpinnings. The overlap is real enough to keep researchers interested and clinicians careful, but not enough to collapse two categories into one.